Company profile
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical
- CEO
- —
- Headquarters
- Chengdu, China
- Employees
- 298
- IPO date
- Aug 12, 2024
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic